clinical trial · NCT06619392
A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects
Shandong Suncadia Medicine Co., Ltd.·phase1·completed·n = 44
PainHRS-2129HRS-2129 Placebo
brief summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics in healthy subjects, and to evaluate the food effect on pharmacokinetics of HRS-2129.
started
Oct 17, 2024
primary completion
Jan 20, 2025
completion
Jan 20, 2025
last updated
Mar 5, 2025
official title
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of HRS-2129 and the Food Effect on Pharmacokinetics Following Single Dose Administration in Healthy Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol